top of page
Search

Your Child May Qualify for Disability Benefits
The following article was written by Rachel Gaffney. If you would like additional information, you can contact Rachel at rsg@ssd-help.org.
cmrouth
Nov 22, 20201 min read
35 views
0 comments

Stanford Study on Immune Therapy Treatment of AT/RT
https://scopeblog.stanford.edu/2020/04/30/new-advances-toward-safely-targeting-immune-cells-to-pediatric-brain-tumors/
cmrouth
Jun 2, 20201 min read
53 views
1 comment

For Families Facing Malignant Rhabdoid Tumors, Reasons to Hope (repost from DFCI)
Since 2008, Cure ATRT Now, has been funding ATRT targeted research at Dana Farber & St Jude’s hospital. This inspiring story is the...
cmrouth
Jan 24, 20201 min read
52 views
0 comments

Epizyme Research Update
We continue to fight to find a cure for ATRT. This is a long & complicated fight but we are making progress, albeit slowly. This is the...
cmrouth
Nov 6, 20171 min read
75 views
0 comments

cmrouth
Mar 6, 20160 min read
96 views
1 comment

Epizyme launches dosing program
Epizyme announces first patient dosed in global clinical program. Dana Farber Cancer Institute and Cincinnati Children's Hospital are the...
cmrouth
Dec 31, 20151 min read
58 views
0 comments

New Research Posted
New research posted to the We Can Help -> Research section of the web site. Pitfalls in Diagnosing AT/RT: Experiences From the European...
cmrouth
Dec 30, 20151 min read
22 views
0 comments
Welcome!
Welcome to the new Cure ATRT Now website. When we started Cure ATRT Now, it was just a few frightened parents frustrated by the scarcity...
Cure ATRT Now
Oct 3, 20151 min read
46 views
0 comments

Epizyme European Cancer Conference Recap
This presentation contains a lot of information, much of it very technical. The study is not specific to AT/RT, but does include AT/RT...
cmrouth
Sep 28, 20151 min read
26 views
0 comments

FDA Accepts Drug in Phase 1 study INI1-Negative Tumors, Including AT/RT
Epizyme, Inc. a clinical stage biopharmaceutical company creating novel epigenetic therapies for patients with cancer, today announced...
cmrouth
Aug 24, 20151 min read
24 views
0 comments

What is AT/RT Cancer?
For those just learning about AT/RT, here is an helpful post from the Dana Farber Cancer Institute: http://blog.dana-farber.org/insight/2...
cmrouth
Aug 6, 20151 min read
47 views
0 comments

Phase 1 Dose Escalation Shows Promise
Barcelona, Spain, November 20, 2014 – Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative...
cmrouth
Nov 20, 20141 min read
20 views
0 comments
bottom of page